Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer
Clinical trial NCT00392821 · COMPLETED
Trial details
- NCT number
- NCT00392821
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2013-10-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.